These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19120715)

  • 21. Treating systolic hypertension in the very elderly with valsartan-hydrochlorothiazide vs. either monotherapy: ValVET primary results.
    Izzo JL; Weintraub HS; Duprez DA; Purkayastha D; Zappe D; Samuel R; Cushman WC
    J Clin Hypertens (Greenwich); 2011 Oct; 13(10):722-30. PubMed ID: 21974759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy.
    Mallion JM; Carretta R; Trenkwalder P; Martinez JF; Tykarski A; Teitelbaum I; Oddou P; Fagan T;
    Blood Press Suppl; 2003 May; 1():36-43. PubMed ID: 12800986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) study.
    Wright RF; Duprez D; Purkayastha D; Samuel R; Ferdinand KC
    J Clin Hypertens (Greenwich); 2011 Aug; 13(8):588-97. PubMed ID: 21806769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients.
    Jordan J; Engeli S; Boschmann M; Weidinger G; Luft FC; Sharma AM; Kreuzberg U
    J Hypertens; 2005 Dec; 23(12):2313-8. PubMed ID: 16269974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valsartan: more than a decade of experience.
    Black HR; Bailey J; Zappe D; Samuel R
    Drugs; 2009; 69(17):2393-414. PubMed ID: 19911855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies.
    Nash DT; Crikelair N; Zappe D
    Curr Med Res Opin; 2008 Sep; 24(9):2617-26. PubMed ID: 18687165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial.
    Ridker PM; Danielson E; Rifai N; Glynn RJ;
    Hypertension; 2006 Jul; 48(1):73-9. PubMed ID: 16714425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study.
    Klingbeil AU; John S; Schneider MP; Jacobi J; Weidinger G; Schmieder RE
    J Hypertens; 2002 Dec; 20(12):2423-8. PubMed ID: 12473867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study.
    Sharma AM; Davidson J; Koval S; Lacourcière Y
    Cardiovasc Diabetol; 2007 Oct; 6():28. PubMed ID: 17910747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy.
    Fogari R; Zoppi A; Mugellini A; Preti P; Destro M; Rinaldi A; Derosa G
    Adv Ther; 2006; 23(5):680-95. PubMed ID: 17142202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker.
    Uzu T; Sakaguchi M; Yokomaku Y; Kume S; Kanasaki M; Isshiki K; Araki SI; Sugiomoto T; Koya D; Haneda M; Kashiwagi A
    Clin Exp Nephrol; 2009 Aug; 13(4):300-306. PubMed ID: 19255824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valsartan plus hydrochlorothiazide: a review of its use since its introduction.
    Bains J; Smith WB
    Expert Opin Pharmacother; 2011 Aug; 12(12):1975-84. PubMed ID: 21728903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension.
    Calhoun DA; Lacourcière Y; Crikelair N; Jia Y; Glazer RD
    Curr Med Res Opin; 2013 Aug; 29(8):901-10. PubMed ID: 23721363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure control with angiotensin receptor blocker-based three-drug combinations: key trials.
    de la Sierra A; Barrios V
    Adv Ther; 2012 May; 29(5):401-15. PubMed ID: 22610686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic efficacy of valsartan and valsartan/HCTZ in mild to moderate hypertensive patients].
    Sun NL; Wang HY; Zhu JR;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug; 35(8):715-8. PubMed ID: 17963629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of valsartan and hydrochlorothiazide alone and in combination on blood pressure and heart rate in conscious-telemetered spontaneously hypertensive rats (SHR).
    Webb RL; Navarrete AE; Davis S
    Am J Hypertens; 1998 Jan; 11(1 Pt 1):59-65. PubMed ID: 9504451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
    Calhoun DA; Lacourcière Y; Chiang YT; Glazer RD
    Hypertension; 2009 Jul; 54(1):32-9. PubMed ID: 19470877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial combination therapy compared with monotherapy in diabetic hypertensive patients.
    Sowers JR; Lastra G; Rocha R; Seifu Y; Crikelair N; Levy DG
    J Clin Hypertens (Greenwich); 2008 Sep; 10(9):668-76. PubMed ID: 18844761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.